Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
270 results found
2022 ∙ ACIP
Updates from the Pneumococcal Vaccines Work Group
Background paper Americas United States of America Pneumococcal disease
Download:
2021 ∙ SAGE
Considerations for pneumococcal vaccination in older adults
SAGE background document Pneumococcal disease
Download:
2021 ∙ SAGE
Pneumococcal vaccines: WHO position paper on their use in community outbreak settings
Position paper Pneumococcal disease
Download:
2021 ∙ Wang, B. C. Chaiyakunapruk, N. Zhu, S. Babigumira, J. B. Furnback, W. Chitale, R. Gamil, A. Zhao, K. Wasserman, M.
A systematic literature review of economic evaluations of pneumococcal conjugate vaccines in east and southeast Asia (2006-2019)
Western Pacific Children Newborn Pneumococcal disease Economic aspects
Rating:
Not applicable
2021 ∙ Shao, Y. Stoecker, C.
Cost-effectiveness of pneumococcal vaccines among adults over 50 years old in low- and middle-income countries: a systematic review
Adults Older adults Low and Middle Income Countries Pneumococcal disease Economic aspects
Rating:
Not applicable
2021 ∙ Ishiwada, N.
Current situation and need for prevention of invasive pneumococcal disease and pneumococcal pneumonia in 6- to 64-year-olds in Japan
Western Pacific Japan All age groups Pneumococcal disease Coverage Economic aspects
Rating:
Not applicable
2021 ∙ Rosamilia, F. Noberasco, G. Olobardi, D. Orsi, A. Icardi, G. Lantieri, F. Murdaca, G.
Flu and pneumococcal vaccine coverage in scleroderma patients still need to be prompted: A systematic review
All age groups Influenza Pneumococcal disease Coverage Acceptance
Rating:
Not applicable
2021 ∙ Wang, L. M. Hashiguchi, T. C. O. Cecchini, M.
Impact of vaccination on carriage of and infection by antibiotic-resistant bacteria: A systematic review and meta-analysis
All age groups Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
2021 ∙ Marques Antunes, M. Duarte, G. S. Brito, D. Borges, M. Costa, J. Ferreira, J. J. Pinto, F. J. Caldeira, D.
Pneumococcal vaccination in adults at very high risk or with established cardiovascular disease: systematic review and meta-analysis
Adults Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
2021 ∙ Zhu, X. Li, X.
Pneumococcal vaccine effect on hospitalisation rates of pneumonia in children: A meta-analysis
Newborn Children Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
Loading...